LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline for blood cancer patients: extended access to promising drug
Disease control OngoingThis study offers continued access to ibrutinib for people with certain blood cancers or graft-versus-host disease who completed earlier ibrutinib trials and are still benefiting from the drug but cannot get it commercially. About 297 participants will receive ibrutinib while res…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
No new treatment, just Check-Ups: gene therapy patients monitored for 15 years
Knowledge-focused ENROLLING_BY_INVITATIONThis study does not provide any new treatment. It follows about 1,000 adults who previously received CAR T-cell gene therapy at the NIH. Researchers will check for long-term side effects through blood tests, clinic visits, and annual phone calls for up to 15 years, as required by…
Matched conditions: LEUKEMIA, B-CELL
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC